QPharma Advises Life Sciences Organizations to Prepare for Sunshine Act Reporting

MORRISTOWN, N.J.--()--QPharma is advising its life sciences clients to be aware of regulatory updates, trends, and reporting deadlines outlined by the Physician Payments Sunshine Act and similar state-level laws. For example, Nevada’s annual certification of a company’s compliance program is due by June 1, and disclosure reports for Massachusetts and Washington, D.C. are due by July 1. And in recent weeks, the Center for Medicare & Medicaid Services (CMS) released new fact sheets regarding its OPEN PAYMENTS program, which is designed to increase transparency around financial relationships between manufacturers, physicians, and teaching hospitals.

QPharma’s proactive approach to regulatory compliance is facilitated by a combination of consultative expertise and the delivery of innovative technology solutions — including qSpend®, a Software-as-a Service solution for tracking and reporting Aggregate Spend activities. Other offerings include a SCORM-compliant Sunshine Act eLearning course for delivery on online learning management systems. QPharma’s Sunshine Act compliance services are further complemented by a partnership with a leading, compliance-focused law firm.

In preparing for compliance with the Sunshine Act, QPharma is advising life sciences firms to strive for promptness and accuracy. “The better that manufacturers understand the necessity of timely and thorough reporting, the less need there will be for corrective actions later on,” explained Ed Sleeper, Managing Director, Commercial Strategies and Solutions at QPharma. “This is especially true given the many layers of detail encompassed by the Sunshine Act and similar state reporting laws.” Companies seeking more information about QPharma’s Sunshine Act solutions can contact Mr. Sleeper, at (973) 656-0011 or ed.sleeper@qpharmacorp.com.

About QPharma, Inc.

QPharma provides a suite of services and solutions to the life sciences industry. Services offered by the company’s Professional Services division include complete validation services, project management, auditing, and training. The Commercial Services division provides solutions in such areas as aggregate spend reporting, PDMA compliance, online training, warehousing and fulfillment, and brand marketing and sales support. The company’s engineers, regulatory compliance experts, and brand consultants have been proudly serving the life sciences industry since 1994. To learn more, visit www.qpharmacorp.com.

Contacts

QPharma, Inc.
Brendan Middleton, 973-656-0011, Ex. 2112
Director of Marketing and Public Relations
brendan.middleton@qpharmacorp.com

Release Summary

QPharma is advising its life sciences clients to be aware of the latest regulatory trends and updates in preparation for upcoming Sunshine Act reporting and similar state regulation deadlines.

Contacts

QPharma, Inc.
Brendan Middleton, 973-656-0011, Ex. 2112
Director of Marketing and Public Relations
brendan.middleton@qpharmacorp.com